Novel approaches are significantly reshaping the paradigm for metabolic disease . MOTS-c, representing several substances , present potential avenues in addressing conditions like type two glucose intolerance and excessive weight . While studies are still in progress , preliminary results imply substantial improvements in glucose management and we